retatrutide weight loss results clinical trial Retatrutide: A Multi-Receptor Approach to Management A new clinical trial from

Who Is a Good Candidate for Each Medication

Update: An October 2024 Clinical Practice Guidance joint statement by multiple medical societies (American Society of Anesthesiologists (ASA), American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and the Society of American Gastrointestinal and Endoscopic Surgeons) states that most patients should continue taking their GLP-1 drugs before elective surgery

Semaglutide targets one receptor (GLP-1)

The standard 0.5 mg starting protocol A 0.5 mg weekly starting dose has become increasingly popular outside of formal clinical trials

For example, patients with binge eating disorder or night-eating syndrome may benefit from GLP-1 RA therapy as long as they also receive proper psychological/psychiatric care

The diagram rescales to that syringe, so the same dose sits at a different mark on a 0.3 mL barrel than on a U-100